Tranexamic Acid (TXA)

Tranexamic Acid

The CRASH-2 2 (Clinical Randomisation of an Anti-fibrinolytic in Significant Haemorrhage 2) study involved the randomisation of over 20,000 patients with, or at risk of significant haemorrhage in 40 countries. The study demonstrated a 32% reduction in death due to haemorrhage, when tranexamic acid is administered within 1 h of injury. The study concluded that tranexamic acid safely reduced the risk of death in bleeding trauma patients, and should be considered for use in practice.

Following the publication of the study, the Trust has been working with Professor Stuart Logan, Director of the Peninsula National Institute of Health Research's Collaboration for Leadership in Applied Health Research and Care to implement the intervention across the South West.

For further information please contact Adrian South, Deputy Director of Clinical Care at adrian.south@swast.nhs.uk

Local Resources

Published Evidence

TXA image

Email this page Print page

News

Choose well this summer and help us get to those who need our help most
South Western Ambulance Service NHS Foundation Trust (SWASFT) is urging residents and visitors to the region this summer to choose well when it comes to accessing healthcare. SWASFT is handling an extra 470 incidents per day compared with five-years ago and is expecting to deal with more than 10,000 calls over the bank holiday weekend. If you need medical help but it is not an emergency consider other alternatives and help keep 999 and hospital emergency departments (EDs) free for those most in need. A large proportion of the calls we receive are not for time critical, life threatening emergency situations and so we are encouraging people to think twice before they call.
24/08/2016

Rounded corners
Rounded corners
 
© South Western Ambulance Service NHS Foundation Trust 2016 Design by Precedent | Powered by Sitekit